Geron Corporation (GERN)
Geron Corporation Market Cap: 187.81M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
GERN Market Cap Rankings
| Overall | 32nd percentile | 3123 of 4650 |
| Sector | 43rd percentile | 297 of 525 in Healthcare |
| Industry | 50th percentile | 82 of 164 in Biotechnology |
GERN Market Cap Range, Past 5 Years
| Minimum | 187.81M | May 25 2012 |
| Maximum | 683.01M | Jun 2009 |
| Average | 442.54M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these GERN related companies
GERN News
$GERN link to court materials and some discussion http://stks.co/3ynx
about 5 days ago by BrantleyFoster
about 5 days ago by BrantleyFoster
long $GERN adding to my position at support @1.39. Mean price now @1.71, patience on this one, now in phase II cell lung cancer trial.
about 6 days ago by kotekaz
about 6 days ago by kotekaz
$GERN what is this court ruling in 5 days on $GERN everyone is talking about???
about 8 days ago by BiopharmaPro
about 8 days ago by BiopharmaPro
$gern analysts 12-month price forecasts of 3.00 .The median estimate represents a +102.02% increase from last price 1.49. that's double play
about 18 days ago by GOTUBRAD
about 18 days ago by GOTUBRAD
Small Biotechs Like Aastrom Biosciences and Geron Likely to Benefit From New Patent System
May 09, 8:20AM Marketwire
May 09, 8:20AM Marketwire
$ZGNX and $GERN becoming even more interesting now $NVAX not so bad today
about 21 days ago by micheleciani
about 21 days ago by micheleciani
Geron Completes Enrollment in Phase 2 Clinical Trial of Imetelstat in Non-Small Cell Lung Cancer
May 03, 7:31AM Thomson Reuters ONE
May 03, 7:31AM Thomson Reuters ONE
Geron Corporation Reports 2012 First Quarter Financial Results and Highlights
May 02, 4:02PM Thomson Reuters ONE
May 02, 4:02PM Thomson Reuters ONE
Geron Announces Conference Call to Discuss First Quarter 2012 Financial Results
Apr 25, 7:32AM Thomson Reuters ONE
Apr 25, 7:32AM Thomson Reuters ONE
$GERN http://stks.co/3Rbu broke the trendline yesterday in a very good volume. suppose to keep the long way till 1.89
about 38 days ago by lalior
about 38 days ago by lalior
3 Great stock on our radar: $NVAX $ZGNX $GERN we ll reenter soon. Take a look at $SQNM now, we were screaming buy it at $3,2 10 days ago
about 39 days ago by micheleciani
about 39 days ago by micheleciani
Take a look at the other stocks in our radar $NVAX $ZGNX $GERN all working great today
about 39 days ago by micheleciani
about 39 days ago by micheleciani
Listen to $GERN Geron at BioCentury & Thomson Reuters Future Leaders in the Biot - live at 10:30 AM, ondemand after - http://stks.co/3R1u
about 39 days ago by earningscast
about 39 days ago by earningscast
Take a look at $GERN, tomorrow could exit UP from the descending channel. This will be a BULLISH signal. TP$5. We like it with $NVAX $ZGNX
about 40 days ago by micheleciani
about 40 days ago by micheleciani
Lot's of red ink on my biotech watchlist...$ARNA, $KERX, $CHTP, $GERN, definitely some good buys for those with cash
about 41 days ago by swingtrades99
about 41 days ago by swingtrades99
Geron to Present at the Future Leaders in the Biotech Industry Conference
Apr 17, 7:32AM Thomson Reuters ONE
Apr 17, 7:32AM Thomson Reuters ONE
$AMRN waiting for it around $8, $GERN $NVAX on our radar. $FIO could bounce UP back near $25, it's in a triangle between $30 and $25 now
about 42 days ago by micheleciani
about 42 days ago by micheleciani
Geron Corporation Reports Fourth Quarter and Annual 2011 Financial Results
Mar 07, 4:08PM Thomson Reuters ONE
Mar 07, 4:08PM Thomson Reuters ONE
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2011 Financial Results
Feb 28, 7:33AM Thomson Reuters ONE
Feb 28, 7:33AM Thomson Reuters ONE
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GERN | 1.42 | +0.03 | +2.16% | 187.81M |
| GEOY | 20.39 | +1.29 | +6.75% | 453.47M |
| FVE | 3.05 | -0.03 | -0.97% | 146.10M |
| FVD | 16.26 | -0.02 | -0.12% | |
| FURX | 19.10 | +0.88 | +4.83% | 190.04M |
| FUR | 10.30 | -0.10 | -0.96% | 340.42M |
| FUND | 6.26 | +0.06 | +0.97% | |
| FUN | 26.60 | +0.13 | +0.49% | 1.473B |
| FULT | 10.24 | -0.04 | -0.39% | 2.051B |
| FSYS | 15.10 | -0.24 | -1.56% | 302.15M |
